Advertisement
Research Article| Volume 64, ISSUE 1, P5-10, April 1984

Anticholinesterase abuse in myasthenia gravis

      This paper is only available as a PDF. To read, Please Download here.

      Abbreviations:

      ACh, acetylcholine (), Anti-ChE, anti-cholinesterase (), ChAT, choline acetyltransferase (), ChE, cholinesterase ()
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of the Neurological Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ashizawa T.
        • Elias S.B.
        • Appel S.H.
        Interaction of myasthenia immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
        Ann. Neurol. 1982; 11: 22-27
        • Brownell B.
        • Oppenheimer D.R.
        • Spalding J.M.K.
        Neurogenic muscle atrophy in myasthenia gravis.
        J. Neurol. Neurosurg. Psychiat. 1972; 35: 311-322
        • Chang C.C.
        • Chen T.F.
        • Chuang S.T.
        Influence of chronic neostigmine treatment on the number of acetylcholine receptors and the release of acetylcholine from the rat diaphragm.
        J. Physiol. (Lond.). 1973; 230: 613-618
        • Coërs C.
        • Telerman-Toppet N.
        Morphological and histochemical changes of motor units in myasthenia.
        Ann. N.Y. Acad. Sci. 1976; 274: 6-19
        • Engel A.G.
        • Lambert E.H.
        • Santa T.
        Study of long-term anticholinesterase therapy — Effects on neuromuscular transmission and on motor end-plate fine structure.
        Neurology (Minneap.). 1973; 23: 1273-1281
        • Hilton-Brown P.
        • Stålberg E.V.
        • Osterman P.O.
        Signs of reinnervation in myasthenia gravis.
        Muscle and Nerve. 1982; 5: 215-221
        • Hudson C.S.
        • Rash J.E.
        • Tiendt T.N.
        • Albuquerque E.X.
        Neostigmine-induced alterations at the mammalian neuromuscular junction, Part 2 (Ultrastructure).
        J. Pharmacol. Exp. Ther. 1978; 205: 340-356
        • Kaita A.A.
        • Goldberg A.M.
        Control of acetylcholine synthesis — The inhibition of choline acetyltransferase by acetylcholine.
        J. Neurochem. 1969; 16: 1185-1191
        • Katz B.
        • Thesleff S.
        A study of the “desensitization” produced by acetylcholine at the motor end plate.
        J. Physiol. (Lond.). 1957; 138: 63-80
        • Kawabuchi M.
        • Osame M.
        • Watanabe S.
        • et al.
        Myopathic changes at the end plate region induced by neostigmine methylsulfate.
        Experientia. (Basel). 1976; 32: 623-635
        • Laskowski M.B.
        • Olson W.H.
        • Dettbarn W.D.
        Ultrastructural changes at the motor end plate produced by an irreversible cholinesterase inhibitor.
        Exp. Neurol. 1975; 47: 290-306
        • Lytle R.B.
        • Wellband W.A.
        Increased synaptic area of neuromuscular junction in neostigmine treated rats.
        Anat. Rec. 1970; 166: 399-404
        • Olanow C.W.
        • Wechsler A.S.
        • Roses A.D.
        A prospective study of thymectomy and serum acetylcholine receptor antibodies in myasthenia gravis.
        Ann. Surg. 1982; 196: 113-121
        • Rowland L.P.
        • Korengold M.C.
        • Jaffe I.A.
        • Berg L.
        • Shy G.M.
        Prostigmine induced muscle weakness in myasthenia gravis patients.
        Neurology (Minneap.). 1955; 5: 89-99
        • Schwartz M.S.
        • Sargeant M.K.
        • Swash M.
        Neostigmine induced end plate proliferation in the rat — A study using supra-vital methylene blue.
        Neurology (Minneap.). 1977; 27: 289-293
        • Tiendt T.N.
        • Albuquerque E.X.
        • Hudson C.S.
        • Rash J.E.
        Neostigmine induced alterations at the mammalian neuromuscular junction, Part 1 (Muscle contraction and electrophysiology).
        J. Pharmacol. Exp. Ther. 1978; 205: 326-339
        • Ward M.D.
        • Forbes M.S.
        • Johns T.R.
        Neostigmine methylsulfate — Does it have a chronic effect as well as a transient one?.
        Arch. Neurol. (Chic.). 1975; 32: 808-813